Chiron Corp.

chiron corp. - All News and Analysis

• Swivelhead spindle VMC designed fop single setups—Chiron America

  - 2008-03-01

  With seven CNC-controlled axes, Chiron's FZ 12K S with swivelhead offers various machining options in one setup, from the bar. Capable of high-precision, automated, six-side machining, the VMC is suited for machining watch casings, medical parts or hydraulic components. Medical applications for this machine include orthopedic devices, such as larger...

  Tags: Chiron Corp.

• Show to feature bomb suspect

  - 2007-08-31

  Daniel Andreas San Diego, an animal rights activist and federal fugitive wanted in connection with two East Bay bombings in 2003, will be featured again this weekend on Fox Network's "America's Most Wanted." San Diego's case first was aired on the television program in March 2004, and...

  Tags: Chiron Corp., FBI, Government

• TV crime show to feature Chiron bombing suspect

  - 2007-08-31

  Daniel Andreas San Diego, an animal rights activist and federal fugitive wanted in connection with two East Bay bombings in 2003, will be featured again this weekend on Fox Network's "America's Most Wanted." San Diego's case first was aired on the television program in 2004, and again...

  Tags: Chiron Corp., FBI, Government, TV

• TV crime show features Chiron bombing suspect

  - 2007-08-31

  Daniel Andreas San Diego, an animal rights activist and federal fugitive wanted in connection with two East Bay bombings in 2003, will be featured again this weekend on Fox Network's "America's Most Wanted." San Diego's case first was aired on the television program in March 2004, and...

  Tags: Chiron Corp., FBI, Government, TV

• Chiron bombing suspect featured

  - 2007-08-31

  Daniel Andreas San Diego, an animal rights activist and federal fugitive wanted in connection with two East Bay bombings in 2003, will be featured again this weekend on Fox Network's "America's Most Wanted." San Diego's case first was aired on the television program in March 2004, and...

  Tags: Chiron Corp., FBI, Government

• TV crime show to feature Chiron bombing suspect

  - 2007-08-31

  Daniel Andreas San Diego, an animal rights activist and federal fugitive wanted in connection with two East Bay bombings in 2003, will be featured again this weekend on Fox Network's "America's Most Wanted." San Diego's case first was aired on the television program in March 2004, and...

  Tags: Chiron Corp., FBI, Government, TV

• Suspected East Bay bomber to be featured on America's Most Wanted

  - 2007-08-30

  Daniel Andreas San Diego, an animal-rights activist and federal fugitive wanted in connection with two East Bay bombings in 2003, will be featured again this weekend on Fox Network's "America's Most Wanted." San Diego's case first was aired on the television program in March 2004, and again in...

  Tags: Chiron Corp., FBI, Government

• Novartis Delivers Dynamic Sales and Earnings Growth in the First Nine Months of 2006, Reaffirms Outlook for Record Full-Year Results

  - 2006-10-19

  -- Group continues double-digit expansion -- Nine-month net sales up 14% (+15% lc) to USD 27.0 billion on strong underlying growth and acquisition-related contributions -- Operating income rises 17%, supported by all divisions...

  Tags: acquisition, Chiron Corp., Microsoft Outlook, Novartis AG

• Former Chiron Exec Joins APT Pharmaceuticals as CEO

  - 2006-09-06

  FOSTER CITY, Calif. -- APT Pharmaceuticals Inc. (http://www.aptbio.com) has named the former chief medical officer of Chiron BioPharmaceuticals, Stephen G. Dilly, M.B.B.S., Ph.D., as chief executive officer.

  Tags: Chiron Corp.

• Research and Markets: A Fourth Division for Novartis under the Title Vaccines & Diagnostics, Will Be Created After the Acquisition of Chiron Corporation

  - 2006-09-01

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c41412) has announced the addition of Espicom Business Intelligence's Novartis Prospects to 2010 to their offering.

  Tags: acquisition, Chiron Corp., Novartis AG, vaccine

• Enzo Named Senior Party in U.S. Patent & Trademark Office Proceeding; Enzo Granted Interferences for Key Nucleic Acid Detection Technology

  - 2006-08-23

  FARMINGDALE, N.Y. -- Enzo Biochem, Inc. (NYSE:ENZ) announced today that the United States Patent and Trademark Office has declared two patent interferences designating an allowable Enzo Life Sciences patent application against patents held by Chiron Diagnostics and Princeton University for nucleic acid detection. Bayer Healthcare LLC, of Tarrytown, NY, is...

  Tags: Bayer AG, Chiron Corp., Company, Enzo Biochem Inc., patent, Princeton University

• Application: Fast, accurate 5-axis machining.

  - 2006-08-01

  Staff From the start, in 1985, the need for five-axis machining was apparent, says Rob Bujeaud, vice-president of manufacturing for Turbocam and its recently created high-production division, TAPS Turbocam Automated Production Systems. Staff...

  Tags: cell, Chiron Corp.

• Chiron Shareholders Approve Novartis Acquisition

  - 2006-04-19

  EMERYVILLE, Calif. -- Chiron Corporation (NASDAQ:CHIR) today announced that Chiron shareholders have approved the amended merger agreement under which Novartis AG (NYSE:NVS) will acquire all Chiron shares it doesn't already own for $48.00 per share in cash. At a special meeting of Chiron shareholders held today, the merger was approved...

  Tags: acquisition, Chiron Corp., Novartis AG, shareholder

• Chiron Announces Initiation of Phase 1 Trial for CHIR-265 In Melanoma; Clinical Testing of Novel Oncology Compound Begins in Patients with Skin Cancer

  - 2006-04-11

  EMERYVILLE, Calif. -- Chiron Corporation (NASDAQ:CHIR) today announced the initiation of a Phase 1 clinical trial of CHIR-265, a selective Raf kinase inhibitor, in patients with melanoma.

  Tags: Chiron Corp., patient

• Proxy Advisory Services Recommend Shareholders Vote in Favor of Chiron's Amended Merger Agreement with Novartis

  - 2006-04-05

  EMERYVILLE, Calif. -- Chiron Corporation (NASDAQ:CHIR) today announced that three independent proxy advisory firms, Institutional Shareholder Services, Proxy Governance, and Glass Lewis & Co., have recommended that Chiron shareholders vote in favor of the company's amended merger agreement with Novartis AG (NYSE:NVS). As announced on April 3, Novartis has increased...

  Tags: Chiron Corp., Novartis AG, shareholder

• Stocks to Watch Tuesday: CHIR, CIEN, INHX.

  - 2006-04-04

  M2 PRESSWIRE-4 April 2006-RumorAlerts.com: Stocks to Watch Tuesday: CHIR, CIEN, INHXC1994-2006 M2 COMMUNICATIONS LTD RDATE:04042006 Sarasota, FL - www.RumorAlerts.com Stocks to Watch on Tuesday, April 4 2006: Chiron Corp. (Nasdaq: CHIR), Ciena Corporation (Nasdaq: CIEN), Inhibitex, Inc. (Nasdaq: INHX): ...

  Tags: Chiron Corp., FINANCE, Investment, MARKETING, Nasdaq Stock Market Inc., stock

• ValueAct Capital to Vote Its Chiron Shares in Favor of Revised Novartis Merger Agreement

  - 2006-04-03

  SAN FRANCISCO and BOSTON -- ValueAct Capital today announced its intention to vote for the amended merger agreement under which Novartis AG would acquire, for $48.00 per share, the 56 percent of Chiron Corporation it does not already own.

  Tags: agreement, Chiron Corp., Novartis AG

• Schaeffer's S&P 500 Index Hot Stocks Features Archer-Daniels-Midland, Chiron, Phelps Dodge, RadioShack, and Bausch & Lomb

  - 2006-04-03

  CINCINNATI -- Among the stocks featured in the April 3 edition of Schaeffer's S&P 500 Index Hot Stocks are Archer-Daniels-Midland (NYSE:ADM), Chiron (NASDAQ:CHIR), Phelps Dodge (NYSE:PD), RadioShack (NYSE:RSH), and Bausch & Lomb (NYSE:BOL). Schaeffer's S&P 500 Index Hot Stocks is just one of the many free market commentaries written everyday...

  Tags: Bausch & Lomb Inc., Chiron Corp., Phelps Dodge Corp., RadioShack Corp., S&P 500

• Chiron Statement on Recommendations by Proxy Advisory Services

  - 2006-03-31

  EMERYVILLE, Calif. -- Chiron Corporation (NASDAQ: CHIR) today noted that two proxy advisory services have reached opposite conclusions regarding their voting recommendations to Chiron shareholders in connection with the proposed acquisition of Chiron by Novartis AG (NYSE: NVS). A special meeting of Chiron shareholders will be held on April 12,...

  Tags: Chiron Corp.

• ValueAct Capital Again Refuses to Meet with Chiron, Condemns Its Use of Scare Tactics to Win Support for Novartis Offer

  - 2006-03-20

  SAN FRANCISCO & BOSTON -- ValueAct Capital today announced that it has declined a second request by Chiron Corporation (Nasdaq: CHIR) to accept a meeting as part of the company's roadshow aimed at convincing Chiron shareholders to support Novartis AG's $45 per share offer for the 56 percent of Chiron...

  Tags: Chiron Corp., Novartis AG